Spring Bank Pharmaceuticals Nasdaq Listed Banner

Investor Overview

  • Webcast Image Webcast
    Spring Bank Pharmaceuticals Top-Line Results of Second Cohort (50mg) of Part A of Phase 2 ACHIEVE Trial  (Replay)
    Thursday, November 16, 2017 8:00 am EST
More events are coming soon.

Corporate Profile

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Read more

Upcoming Events

There are currently no events to display.